New DRGs in Austrian LKF 2020 model

22

May 2020

The document “Changes and innovations in the 2020 models” provides the most significant changes and innovations in the LKF models for the inpatient and outpatient area and in their documentation bases.

A total of 13 new MELs, five for inpatient area, and eight for the outpatient settings, were added to the LKF 2020 model.

The following new MELs were introduced in the inpatient area:

  • MEL10.05 Extraction of pacemaker probes
  • MEL17.03 Reconstructive interventions on the lymphatic system
  • MEL22.28 Pediatric oncological therapy - basic therapy
  • MEL22.29 Pediatric oncological therapy - special therapy
  • MEL22.30 Administration of modified cells

The following new groups were introduced in outpatient care:

  • AMG21.28 Pediatric oncological therapy - basic therapy
  • AMG21.29 Pediatric oncological therapy - special therapy
  • APG00.20 Outpatient visit with a subject-specific initial examination
  • APG00.25 Outpatient follow-up visit
  • APG03.21 Outpatient procedures - ear/nose/throat
  • APG03.25 Outpatient surgery - larynx/trachea
  • APG08.25 Special therapy - pregnancy/childbirth
  • APG20.01 Outpatient care

See the full details here

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more

07

Mar 2022

On February 08, 2022, the Reimbursement Commission of the Social Security Institution released an updated version of the Healthcare Implementation Communique. The main changes relate to the increase in reimbursement fees of services and medical devices by approximately 35-75%.

Read more

03

Mar 2022

In February 2022, two more health apps were introduced in the Directory of digital health applications (DiGAs) at the Federal Office for Drugs and Medical Devices (BfArM) and thus became reimbursable. These apps can be prescribed by physicians and psychotherapists and will be reimbursed by health insurers. In total, thirty health apps are now available at the DiGA Directory.

Read more